GlassScriptPhysician profile
Khalid A Chaudhry
NPI 1861480634
$1,950.37
in general payments reported to CMS, 2019-2025
22 companies · $172 in 2025
The $172 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $375 · 2020: $174 · 2021: $505 · 2022: $356 · 2023: $84.48 · 2024: $284 · 2025: $172.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $540.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $540.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $486.19 | 2019-2025 | Impella |
| Novartis Pharmaceuticals Corporation | $278.84 | 2019-2024 | |
| E.R. Squibb & Sons, L.L.C. | $160.98 | 2019-2024 | Camzyos |
| Abbott Laboratories | $145.08 | 2024 | Coroflow |
| Merck Sharp & Dohme LLC | $121.75 | 2021-2022 | |
| Kestra Medical Technology Services, INC. | $118.62 | 2025 | Assure Wcd |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $76.44 | 2019-2023 | Lifevest |
| Pfizer INC. | $71.41 | 2022 | |
| Amgen INC. | $67.15 | 2019-2024 | Repatha |
| Boston Scientific Corporation | $65.02 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $59.40 | 2021-2022 | |
| Cardiovascular Systems INC. | $54.18 | 2019-2020 | |
| Medtronic Vascular, INC. | $35.76 | 2020 | |
| Sanofi-Aventis U.S. LLC | $31.90 | 2020-2024 | |
| Philips North America LLC | $29.99 | 2022-2023 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $27.57 | 2021-2022 | |
| Biosense Webster, INC. | $24.42 | 2019 | |
| Siemens Medical Solutions USA, INC. | $22.01 | 2020 | |
| Novo Nordisk INC | $21.47 | 2022 | |
| Teleflex LLC | $19.66 | 2022 | |
| Cardiva Medical, INC. | $17.27 | 2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Bard Peripheral Vascular, INC. | $15.26 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Khalid Chaudhry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.